Why the study?
In-hospital mortality after cardiac surgery in ACHD is a feared complication, and an ACHD-specific validated risk score is needed to optimize perioperative risk assessment.
Cohort (n=2,757)
Yes
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Due to the increased success of treating congenital heart disease in childhood, we are now faced with a rapidly growing population of adult patients who were born with anomalies of the heart and/or great vessels. Like the general population, these patients sometimes need surgeries for acquired heart problems, in addition to surgeries they may need for congenital heart problems, but their risks are different. For this reason, the ACHD-specific surgical risk model is a much-needed addition to available STS tools.”
“Operations for ACHD are often complex, especially as patients get older and acquire new problems. Patients with ACHD differ in important ways from the general adult surgical population, for multiple reasons. First are the sequelae from their initial condition. Second are the sequelae from their past surgeries. Finally there are sequelae from acquired diseases of adulthood involving the heart or other organs, such as lungs and liver.”
BACKGROUND In-hospital mortality is a rare, yet feared complication following cardiac surgery in adult congenital heart disease (ACHD). A risk score, developed and validated in ACHD, can be helpful to optimize risk assessment. OBJECTIVES The purpose of this study was to assess the performance of EuroSCORE II components and procedure-related Adult Congenital Heart Surgery (ACHS) score, identify additional risk factors, and develop a novel risk score for predicting in-hospital mortality after ACHD surgery. METHODS We assessed perioperative survival in patients aged >16 years undergoing congenital heart surgery in a large tertiary center between 2003 and 2019. A risk variable-derived PEACH (PErioperative ACHd) score was calculated for each patient. Internal and external validation of the model was undertaken, including testing in a validation cohort of patients operated in a second European ACHD center. RESULTS The development cohort comprised 1,782 procedures performed during the study period. Re-sternotomy was undertaken in 897 (50.3%). There were 31 (1.7%) in-hospital deaths. The PEACH score showed excellent discrimination ability (area under the curve [AUC]: 0.88; 95% CI: 0.83-0.94), and performed better than the ACHS score in our population (ACHS AUC: 0.69; 95% CI: 0.6-0.78; P = 0.0003). A simple 3-tiered risk stratification was formed: PEACH score 0 (in-hospital mortality 0.2%), 1-2 (3.6%), and ≥3 (17.2%). In a validation cohort of 975 procedures, the PEACH score retained its discriminative ability (AUC: 0.75; 95% CI: 0.72-0.77) and was well calibrated (Hosmer-Lemeshow chi-square goodness-of-fit P = 0.55). There was agreement in expected and observed perioperative mortality between cohorts. CONCLUSIONS The PEACH score is a simple, novel perioperative risk score developed and validated specifically for ACHD patients undergoing cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Constantine et al. (2021) conducted a cohort in Adult congenital heart disease (ACHD) (n=2,757). PEACH score vs. ACHS score was evaluated on in-hospital mortality (AUC 0.88, 95% CI 0.83-0.94, p=0.0003).
Synapse has enriched 10 related papers. Consider them for comparative context: